重建显微外科方法治疗坏疽性脓皮病
本文回顾性评估5例坏疽性脓皮病(PG)患者下肢8处缺损在免疫抑制和糖皮质激素治疗下接受显微血管游离组织移植的结果,平均缺损面积93 cm²,随访无皮瓣丢失,作者认为PG确诊后并非游离皮瓣移植的禁忌证。
要点
- PG确诊后不是显微血管游离组织移植的禁忌证。
- 所有手术治疗均应在充分的保护性免疫抑制治疗下进行。
- 若缺损需游离皮瓣覆盖,尽管存在PG同形反应风险,仍可考虑作为手术选择。
核心结论
- PG一旦确诊,并非显微血管游离组织移植的禁忌证。
- 每例患者的多学科评估至关重要。
- 所有手术治疗均应在充分的保护性免疫抑制治疗下进行。
- 若缺损需要游离皮瓣覆盖,尽管PG存在同形反应的潜在风险,仍可考虑作为手术选择,且在作者所有病例中是安全的治疗选择。
研究设计与样本
- 回顾性评估5例坏疽性脓皮病(PG)下肢缺损患者共8处缺损,在免疫抑制和糖皮质激素治疗下接受显微血管游离组织移植闭合缺损。
主要发现
- 患者平均年龄60岁,男性3例、女性2例。
- 7处缺损以游离股薄肌肌瓣覆盖,1例患者接受股前外侧皮瓣。
- 平均缺损面积93 cm²。
- 随访期间未见皮瓣丢失。
- 所有患者接受广谱抗生素和糖皮质激素治疗,其中2例还接受英夫利西单抗治疗。
临床怎么用
- 作者认为PG确诊后不是显微血管游离组织移植的禁忌证。
- 作者认为每例患者的多学科评估至关重要。
- 作者认为所有手术治疗均应在充分的保护性免疫抑制治疗下进行。
- 作者认为若缺损需要游离皮瓣覆盖,尽管存在PG同形反应的潜在风险,仍可考虑作为手术选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pyoderma gangrenosum (PG) is a rare type of autoimmune disease that results in progressive ulcers with or without previous trauma. However, PG is not well understood to date, and its treatment therefore remains a challenge. Because of the disease's systemic characteristic and the unpredictability of the clinical course, no gold standard treatment is available, especially concerning the surgical procedures to treat pyodermic lesions. Often, PG is not recognized during routine clinical practice, and standard ulcer treatment (conservative wound care, debridement, skin grafting, and local flap coverage) is initiated; this induces an autoinflammatory response, resulting in disastrous ulcers, thereby making free flap coverage necessary. The purpose of this study was to assess the outcome of microvascular free-tissue transfer as a treatment option for extended soft-tissue defects resulting from PG. MATERIALS AND METHODS: We retrospectively evaluated 8 cases in 5 patients suffering from PG of the lower extremity who received defect closure with a microvascular free-tissue transfer under immunosuppressive and corticosteroid therapy. RESULTS: The average patient age was 60 years; three were male, and two were female. Seven defects were covered with free gracilis muscle flap. One patient received an anterolateral thigh flap. The average defect size was 93 cm2. No flap loss was observed during follow-up. All patients received broad-spectrum antibiotic treatment and corticosteroids. Two patients also received infliximab. DISCUSSION AND CONCLUSION: PG once diagnosed is not a contraindication for microvascular free-tissue transfer. Multidisciplinary evaluation of each case is fundamental. All surgical treatments should be performed only with sufficient protective immunosuppression therapy. If the defect requires free flap coverage, it should be considered as a surgical option despite the potential risk of a pathergic response in PG and was a safe treatment option in all our cases. In conclusion, we share our experience regarding preoperative, intraoperative, and postoperative care of patients with PG receiving free flap surgery.
引用
- Schwaiger K, Russe E, Kholosy H, et al. Reconstructive microsurgical approach for the treatment of pyoderma gangrenosum. J Plast Reconstr Aesthet Surg. 2017. PMID: 28918934. doi:10.1016/j.bjps.2017.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。